September 14, 2023 – Praedicat President and CEO Robert Reville discusses the conversations he’s having in Monte Carlo around the growth of casualty, the challenges insurers and reinsurers are facing,…
read moreFilter posts by:
September 12, 2023 – This morning in Monte Carlo, longtime Praedicat Inc. friend Meg Green and our CEO Robert Reville caught up to discuss the impact of PFAS on the…
read moreMonte Carlo 2023 Coverage September 11, 2023: In the face of rising litigation, how is the industry managing liability exposure to per- and polyfluoroalkyl substances (PFAS)? That is the question…
read moreAugust 30, 2023: D&O Underwriters May Be Worried About the Wrong Greenhouse Gas Greenwashing lawsuits with respect to climate change, while still relatively uncommon, have seen an uptick in recent…
read moreIncreasingly, climate advocates are turning to the courts to seek accountability and redress, and that means new climate-related emerging risks for casualty insurers. Praedicat is making it easier for insurers…
read moreClimate casualty risk Increasingly, climate advocates are turning to the courts to seek accountability and redress, and that means new climate-related emerging risks for casualty insurers. It soon may be…
read morePraedicat is excited to return to Monte Carlo for the Rendez-Vous de Septembre (RVS) this year, September 10th – 13th. Our team looks forward to (re)connecting with our friends and…
read morePraedicat Blog – So, I can’t have my cake and eat it too? by Dave Loughran The first non-nutritive sweetener saccharin was discovered accidentally in 1878 by a Johns Hopkins researcher investigating…
read morePraedicat Blog – Is aspartame the next glyphosate? by Adam Grossman and Sheryll Mangahas In March 2015, the World Health Organisation’s (WHO) International Agency for Research on Cancer (IARC) declared…
read morePraedicat’s Nekomodel is our cutting-edge modeling technology that revolutionizes the way companies assess their exposure to emerging risks, and Nekomodel X is the next generation of our advanced risk assessment…
read moreJuly 2023 – The PFAS investment opportunity PFAS may very well be the next asbestos. But PFAS may also be the next big investment opportunity. If you are skeptical, we…
read moreJune 8, 2023: Endocrine Disruption Litigation Has Arrived In their latest article for Carrier Management, Praedicat’s David Loughran and Adam Grossman explore the emergence of endocrine disruption as a major…
read more